Search results
Results from the WOW.Com Content Network
The National Health Regulatory Authority (NHRA) is an independent regulatory body established in 2010, under Law No. 38 of 2009, of the Kingdom of Bahrain. [1]Bahrain's hospitals, medical centres, pharmacies, physicians, surgeons, nurses, pharmacists, medical technicians and allied healthcare institutions and healthcare professionals must be registered with, and/or licensed, by NHRA.
Government-provided health care is free to Bahraini citizens and subsidized for non-Bahrainis. Healthcare expenditure accounted for 4.5% of Bahrain's GDP, according to the World Health Organization. Bahraini physicians and nurses form a majority of the country's workforce in the health sector, unlike neighbouring Gulf states. [2]
The fourth Vaccine approved by Bahrain’s NHRA is Sputnik V COVID-19 vaccine [15] The National Health Regulatory Authority (NHRA) has also authorized, as the fifth vaccine, the emergency use of Janssen COVID-19 vaccine from Johnson and Johnson. [16] Bahrain became the first country in the world to approve this particular vaccine. [17]
This is a list of hospitals in Bahrain. Hospitals in Bahrain can be classified into public hospitals (funded by the Ministry of Health or the Bahrain Defence Force ) and private hospitals. All hospitals are subject to inspection and accreditation by the National Health Regulatory Authority (NHRA), an independent regulatory body established in 2010.
In 2017, the main branch in Manama and the satellite branches in Saar and Amwaj Islands have been awarded Diamond status – the highest level of accreditation given to hospitals by the National Health Regulatory Authority (NHRA) of Bahrain. The accreditation is awarded, after NHRA's assessment, once, every three years. [50]
A stringent regulatory authority is a regulatory authority which is: a) a member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), being the European Commission, the US Food and Drug Administration and the Ministry of Health, Labour and Welfare of Japan also represented by the Pharmaceuticals and Medical Devices Agency (as before ...
This process is performed within a legal framework defining the requirements necessary for successful application to the regulatory authority, details on the assessment procedure (based on quality, efficacy and safety criteria), and also the circumstances where a marketing authorisation already granted may be withdrawn, suspended or revoked. [1]
National Health Regulatory Authority (Bahrain) P. Prime Minister of Bahrain; Public Security Forces This page was last edited on 8 September 2020, at 01:39 (UTC). ...